<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03045601</url>
  </required_header>
  <id_info>
    <org_study_id>2016/1609</org_study_id>
    <nct_id>NCT03045601</nct_id>
  </id_info>
  <brief_title>Diagnostic Accuracy of CT-FFR Compared to Invasive Coronar Angiography With Fractional Flow Reserve</brief_title>
  <official_title>Diagnostic Accuracy of Coronary Computed Tomographic Angiography Derived Fractional Flow Reserve Compared to Invasive Coronar Angiography With Fractional Flow Reserve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Olavs Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Invasive coronary angiography is currently considered gold standard in the assessment of&#xD;
      coronary artery disease although the method has limitations. Most importantly invasive&#xD;
      angiography only depicts coronary anatomy without determining its physiological significance&#xD;
      i.e the likelihood that the stenosis impedes oxygen delivery to the heart muscle. Fractional&#xD;
      flow reserve (FFR) is a catheterization technique for assessing the physiological&#xD;
      significance of a coronary artery lesion during invasive coronary angiography. Coronary&#xD;
      computed tomographic angiography (CCTA) is a noninvasive imaging test that has become an&#xD;
      alternative route to diagnosis for patients with suspected coronary artery disease.&#xD;
      Computational fluid dynamics combined with anatomical models based on CCTA scans allows&#xD;
      determination of coronary flow and pressure, and has emerged as a promising diagnostic&#xD;
      modality called CT-FFR. In this Project New Mathematical algorithms are developed for&#xD;
      computation of CT-FFR. The main objective of this study is to determine the diagnostic&#xD;
      accuracy of CT-FFR values obtained by the new method compared with invasive coronary&#xD;
      angiography with fractional flow reserve and state-of-the-art dobutamin stress&#xD;
      echocardiography.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 21, 2017</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CT- FFR values by New Method as a dichotomous variable</measure>
    <time_frame>4 weeks</time_frame>
    <description>Determining the diagnostic accuracy of CT-FFR values obtained by the new method compared with invasive coronary angiography with fractional flow reserve</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Worsening regional wall motion abnormality</measure>
    <time_frame>4 weeks</time_frame>
    <description>Determining the diagnostic accuracy of invasive FFR with comprehensive stress echocardiographic techniques</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">182</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>CT-FFR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Analyse With New CT-FFR Method</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stress echocardiography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Analyse With invasive FFR and stress echocardiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CT-FFR</intervention_name>
    <description>Invasive FFR and CCTA With CT-FFR</description>
    <arm_group_label>CT-FFR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Stress echocardiography</intervention_name>
    <description>Stress echocardiography and invasive FFR</description>
    <arm_group_label>Stress echocardiography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  Proven stenosis by CCTA that require further investigation with invasive coronary&#xD;
             angiography i.e. patients with estimated stenosis â‰¥30- 50%.&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with unstable coronary artery disease.&#xD;
&#xD;
          -  Previously treated with PCI or coronary surgery.&#xD;
&#xD;
          -  Severe renal impairment i.e. GFR &lt;30ml / min&#xD;
&#xD;
          -  Contrast allergy&#xD;
&#xD;
          -  Contraindication to adenosine / nitroglycerin / beta-blocker&#xD;
&#xD;
          -  BMI&gt; 40&#xD;
&#xD;
          -  Patients referred on the basis of technically unsuccessful CTA, motion artifact or&#xD;
             similar&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petter Aadahl, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Olavs Hospital, Klinikk for hjertemedisin</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 26, 2017</study_first_submitted>
  <study_first_submitted_qc>February 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diagnostic Techniques, Cardiovascular</keyword>
  <keyword>Coronary Angiography</keyword>
  <keyword>Fractional Flow Reserve, Myocardial</keyword>
  <keyword>Echocardiography, Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

